Download Files:
ML 315
SKU
HY-117608-10mg
Category Reference compound
Tags Cancer; Neurological Disease, CDK;DYRK, Cell Cycle/DNA Damage;Protein Tyrosine Kinase/RTK
$326 – $521
Products Details
Product Description
– ML 315 is a selective dual inhibitor of CDK and DYRK with IC50s of 68 nM and 282 nM, respectively. ML 315 is used in cancer and neurological disease research[1].
Web ID
– HY-117608
Shipping
– Room temperature
Molecular Formula
– C18H13Cl2N3O2
References
– [1]Coombs TC, et al. Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315. Bioorg Med Chem Lett. 2013 Jun 15;23(12):3654-61.
CAS Number
– 1440251-53-5
Molecular Weight
– 374.22
SMILES
– ClC1=CC(CNC2=NC=NC=C2C3=CC=C4OCOC4=C3)=CC(Cl)=C1
Clinical Information
– No Development Reported
Research Area
– Cancer; Neurological Disease
Solubility
– 10 mM in DMSO
Target
– CDK;DYRK
Pathway
– Cell Cycle/DNA Damage;Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.